美国青少年及家长对侵袭性脑膜炎球菌病疫苗接种的偏好
本研究采用离散选择实验,调查16-23岁青少年及11-17岁青少年的家长对脑膜炎球菌疫苗的偏好。407名青少年和394名家长参与,结果显示保护水平和轻中度副作用风险是最重要属性,加入五价疫苗选项可提高接种意愿,尤其在疫苗犹豫、无保险和成人群体中。
要点
- 保护水平(相对属性重要性33.7%)和轻中度副作用风险(32.3%)是最重要属性。
- 接种方案对家长的重要性(5.9%)高于青少年(2.0%),差异有统计学意义(p<.01)。
- 加入五价疫苗选项使家长接种意愿提高3.7个百分点,青少年提高2.4个百分点。
核心结论
- 保护水平和轻中度副作用风险是脑膜炎球菌疫苗最重要的属性;加入五价疫苗选项可提高接种意愿,尤其在成人、疫苗犹豫者和无保险人群中。
研究设计与样本
- 离散选择实验,纳入16-23岁青少年和11-17岁青少年的家长或法定监护人,共407名青少年和394名家长参与。
主要发现
- 无论疫苗属性如何,59.5%的参与者总是选择接种,3.6%总是选择不接种。
- 保护水平的相对属性重要性为33.7%,轻中度副作用风险为32.3%。
- 接种方案对家长的重要性为5.9%,对青少年为2.0%(p<.01)。
- 加入五价疫苗选项使接种意愿提高:家长3.7个百分点,青少年2.4个百分点,疫苗犹豫者16.4个百分点,无保险者13.4个百分点,成人9.6个百分点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percentage uptake of some meningococcal vaccines is low in the US. Understanding what drives vaccination preferences may help to increase vaccination rates. OBJECTIVES: To determine how attributes of meningococcal vaccines and the availability of a pentavalent (MenABCWY) vaccine profile drive adolescents' and young people's (AYP's) willingness to be vaccinated and parents' and legal guardians' (PLG') willingness for their child to be vaccinated (WTV). To also explore how preferences for meningococcal vaccines vary by participant characteristics. METHODS: Vaccine preferences were elicited in a discrete choice experiment (DCE) with AYP aged 16-23 years and PLG of adolescents aged 11-17 years. Participants chose between two hypothetical vaccine profiles that differed in level of protection, dosing, and risks of mild-to-moderate and severe side effects, and a no vaccination profile. Main outcome measures were relative attribute importance (RAI) and WTV. RAI measured the maximum contribution of an attribute to vaccination choice relative to other attributes. WTV compared predicted choice probabilities for the three vaccine profiles. RESULTS: 407 AYP and 394 PLG participated (50.9% male, 78.4% White/Caucasian). Irrespective of vaccine attributes, 59.5% always opted into vaccination and 3.6% always opted out of vaccination. The most important attributes were level of protection (RAI: 33.7%) and risk of mild-to-moderate side effects (RAI: 32.3%). Dosing was more important to PLG (RAI: 5.9%) than AYP (RAI: 2.0%; p < .01). Adding a pentavalent vaccine alternative increased WTV by 3.7 percentage points (PP) for PLG, 2.4 PP for AYP, 16.4 PP for vaccine-hesitant participants, 13.4 PP for participants without health insurance, and 9.6 PP for adults. CONCLUSION: Level of protection and risk of mild-to-moderate side effects were the most important vaccine attributes. Adding a pentavalent vaccine alternative increased WTV particularly among adults, individuals who were vaccine-hesitant, and individuals without health insurance.
引用
- Schley K, Whichello C, Hauber B, et al. Preferences of US adolescents and parents for vaccination against invasive meningococcal disease. Vaccine. 2024. PMID: 39241319. doi:10.1016/j.vaccine.2024.126264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。